updates in parp inhibition and germline testing in prostate cancer
Published 3 years ago • 542 plays • Length 7:18Download video MP4
Download video MP3
Similar videos
-
16:22
role of parp inhibitors in prostate cancer
-
12:24
the role of targeting dna repair with parp
-
20:05
germline and somatic dna repair defects in prostate cancer
-
14:14
genetic testing and next generation dna sequencing in prostate cancer
-
3:49
the role of targeting dna repair mutations in advanced prostate cancer
-
9:33
genetic testing in prostate cancer
-
21:50
use of germline and somatic molecular testing in prostate cancer diagnosis
-
6:10
genetic testing and parp inhibitors explained | celestial higano, md & mark moyad, md, mph | pcri
-
12:20
parp inhibitors in prostate cancer: choices of tests and how to test?
-
24:54
panel discussion - next generation genomics and prostate cancer biomarkers
-
59:14
parp inhibitors in ovarian cancer: clinical updates from sgo 2023
-
56:49
the role of genetic testing and parp inhibitors (2022)
-
9:51
parp in combination with standard of care treatment
-
59:52
urowebinar parp inhibitor in prostate cancer part iii
-
33:19
castration resistant prostate cancer - developments and challenges from 2020
-
1:10:43
urowebinar: parp inhibitors in prostate cancer part 2
-
14:09
parp inhibitors in prostate cancer: guidelines, who to test and the patient pathway
-
16:03
burning questions and controversies in the management of advanced prostate cancer patients
-
45:44
genetics in prostate cancer: identification of inherited prostate cancer risk